Senestech (NASDAQ:SNES) Stock: Insider Glenbrook Capital Management Buys 36,375 Shares

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 36,375 shares of the company’s stock in a transaction that occurred on Tuesday, October 20th. The shares were bought at an average price of $0.67 per share, for a total transaction of $24,371.25. Following the acquisition, the insider directly owned 2,099,473 shares of the company’s stock, valued at $1,406,646.91. This represents a 1.76% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Thursday, October 22nd, Glenbrook Capital Management acquired 7,500 shares of Senestech stock. The stock was bought at an average cost of $0.80 per share, with a total value of $6,000.00.
• On Wednesday, October 21st, Glenbrook Capital Management purchased 60,000 shares of Senestech stock. The stock was purchased at an average price of $0.74 per share, with a total value of $44,400.00.
• On Monday, October 19th, Glenbrook Capital Management bought 376,552 shares of Senestech stock. The shares were acquired at an average price of $0.70 per share, with a total value of $263,586.40.
• On Friday, October 16th, Glenbrook Capital Management bought 181,252 shares of Senestech stock. The shares were acquired at an average price of $0.63 per share, with a total value of $114,188.76.
• On Thursday, October 15th, Glenbrook Capital Management bought 426,000 shares of Senestech stock. The shares were acquired at an average cost of $0.77 per share, for a total transaction of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management bought 6,490 shares of Senestech stock. The shares were acquired at an average cost of $1.30 per share, for a total transaction of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management purchased 15,000 shares of Senestech stock. The stock was acquired at an average price of $1.30 per share, for a total transaction of $19,500.00.

Senestech Stock Performance

SNES traded up $0.05 during trading hours on Thursday, reaching $0.80. The company’s stock had a trading volume of 396,796 shares, compared to its average volume of 377,329. The company’s 50-day moving average is $0.90 and its 200-day moving average is $1.32. Senestech, Inc. has a 52 week low of $0.55 and a 52 week high of $3.90. The firm has a market cap of $4.33 million, a PE ratio of -0.58 and a beta of 0.25. The company has a debt-to-equity ratio of 0.02, a quick ratio of 5.81 and a current ratio of 6.78.

Senestech (NASDAQ:SNES) last released its quarterly earnings data on Wednesday, August 5th. The company reported ($0.35) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.02. Senestech had a negative net margin of 294.73% and a negative return on equity of 71.89%. The firm had revenue of $0.77 million during the quarter, compared to analysts’ expectations of $0.60 million. On average, equities analysts forecast that Senestech, Inc. will post -1.28 EPS for the current year.

Institutional Investors Weigh In On Senestech

An institutional investor recently bought a new position in Senestech stock. Diversify Wealth Management LLC bought a new stake in Senestech, Inc. (NASDAQ:SNES) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned about 0.36% of Senestech at the end of the most recent quarter. 5.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings cut shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, August 11th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, Senestech currently has a consensus rating of “Sell”.

Senestech Company Profile

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.